Non-Compliance with SOPs Leading to Regulatory Audit Findings
Non-Compliance with SOPs Leading to Regulatory Audit Findings How SOP Non-Compliance Triggers Regulatory Audit Findings in Clinical Trials Introduction: SOPs as the Backbone of Clinical Compliance Standard Operating Procedures (SOPs) provide the framework for conducting clinical trials in compliance with ICH GCP, FDA 21 CFR Part 312, and EMA guidelines. They define responsibilities, ensure consistency,…
Read More “Non-Compliance with SOPs Leading to Regulatory Audit Findings” »